Rakhee Vaidya, MBBS
- Clinical Assistant Professor, Hematology and Oncology

Rakhee Vaidya, MBBS
Research Interests
- Diffuse Large B-Cell Lymphoma
- Double Hit Lymphoma
- Non-Hodgkin Lymphoma
- CAR-T
- Bispecific Antibodies
- Education
- MD, Bombay University Topiwala Medical College - India, 2007
- Residency
- Internal Medicine, Western Reserve Care System, 2009
- Internal Medicine, Mayo Clinic, 2011
- Hematology / Oncology, Mayo Clinic, 2014
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
- Positions
- Clinical Assistant Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements. McPhail ED, Maurer MJ, Macon WR, Feldman AL, Kurtin PJ, Ketterling RP, Vaidya R, Cerhan JR, Ansell SM, Porrata LF, Nowakowski GS, Witzig TE, Habermann TM. Haematologica. 2018 11; 103(11):1899-1907.
- Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Leuk. Lymphoma. 2018 08; 59(8):1871-1877.
- Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma. Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K. Clin Lymphoma Myeloma Leuk. 2016 Feb; 16(2):76-81.
- Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. Vaidya R, Gangat N, Jimma T, Finke CM, Lasho TL, Pardanani A, Tefferi A. Am. J. Hematol. 2012 Nov; 87(11):1003-5.
- Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Vaidya R, Sood R, Karlin N, Jatoi A. Oncology. 2011; 81(1):9-11.
- Study of the Drug Rituximab With and Without Stem Cell Transplant in Treating Mantel Cell Lymphoma
- Study About Prednisone Reduction for Preventing High Blood Sugar in Individuals with B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
- Study of the Drug CPI-613 in Combination with Bendamustine, in Patients with Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma